Anika Therapeutics Inc (ANIK)

Capital Expenditure

-$1.45M

Quarterly · Period ending: · USD

ANIK logo

ANIK Capital Expenditure

Latest reported-$1.45M
ANIK Quarterly CapEx (-$300.00K → -$1.45M)
High-resolution chart · PNG

ANIK capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-1,449,000
-1,431,000
-648,000
-1,887,000
-1,467,000
-2,824,000
-1,307,000
-1,816,000
-3,403,000
-1,808,000
-1,840,000
-741,000
-1,457,000
-1,389,000
-2,529,000
-1,691,000
-1,940,000
-1,326,000
-1,127,000
-1,283,999
-2,315,000
-417,000
-449,000
-271,000
-185,000
-722,999
-268,000
-428,000
-1,101,000
-1,030,000
-163,000
-1,210,000
-740,000
-2,543,000
-2,474,000
-2,589,000
-2,242,000
-1,675,000
-1,406,000
-2,739,000
-3,451,000
-6,418,000
-7,196,907
-894,121
-877,952
-256,020
-632,790
-242,774
-400,845
-276,513
-205,087
-125,932
-74,069
-35,802
-212,220
-146,994
-921,434
-224,059
-446,396
-298,168
-579,214
-76,570
-967,261
-805,417
-226,807
-785,492
-551,407
-845,021
-1,297,218
-1,268,586
-1,372,068
-3,267,707
-8,051,457
-3,555,262
-8,522,297
-3,433,718
-2,140,449
-659,018
-142,756
-130,989
-665,799
-366,257
-516,000
-758,000
-261,000
-65,000
-54,000
-192,000
-79,000
-149,000
-90,000
-33,000
-37,000
-96,000
-13,709
-33,017
-27,318
-14,870
-43,412
-238,701
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.